Fitterfly HealthTech Pvt Ltd Logo
< Back to Listing
Journal Journal
Dec 2022 | Narrative Review | By Dr Arbinder Kumar Singal

Digital therapeutics in diabetes: A significant tool to address employees' health and productivity

Based on estimates in 2021, 74.2 million people with diabetes resided in India which is expected to rise to 124.9 million by 2045. There is an urgent need to strengthen diabetes infrastructure and to ensure access to high-quality, affordable, and appropriate diabetes care at primary, secondary, and tertiary levels. As of October 2022, the labor force in India is close to 429.8 million. Approximately 75% of this huge workforce is estimated to be at higher risk of developing diabetes. Diabetes has been reported to result in lost labor productivity due to absenteeism and presenteeism, and loss of laborers from the workforce due to hospitalizations and complications of DM. DTx has the potential to help in developing a healthier lifestyle among employees while reducing the effect on absenteeism, presenteeism, and loss of employees from the workforce, as well as boosting employee productivity.

Read full paper